BA vs. RTX: Which Aerospace-Defense Stock Is a Smarter Option?

Rising geopolitical tensions and a proposed U.S. fiscal 2026 defense budget (a cited 13.4% increase to ~$1.01 trillion) are boosting prospects for defense primes; Boeing’s BDS reported $9.0B in Q3 2025 awards, a $76B backlog and 25% YoY revenue growth in the quarter, while RTX booked $15.9B in Q3 awards, including a $1.5B Lower Tier sensor contract and a $500M Stinger deal, leaving a $103B backlog as of Sept. 30, 2025. Valuation and balance-sheet contrasts favor RTX (P/S F12M 2.69x vs BA 1.75x; debt-to-capital BA 118.3% vs RTX 37.05%), Zacks EPS revisions show Boeing’s 2025/2026 estimates falling sharply while RTX’s moved slightly higher, and six-month performance favors RTX (+28.8% vs BA +1.6%).

Analysis

Market structure: Rising U.S. defense budgets (proposed +13.4% to ~$1.01T) and large program awards (F‑15EX, F‑47, Space Force $40B) structurally benefit prime contractors (RTX, BA BDS) and tier‑1 suppliers (engines, avionics, sensors). RTX's $103B backlog and $15.9B Q3 bookings imply stronger near‑term revenue visibility than BA's $76B backlog, but BA's BDS 25% YoY growth and tanker deliveries show meaningful upside if operational risk is contained. Commodity pressure (Al, Ti), labor and semiconductor bottlenecks tighten supply, supporting input inflation and margin risk for fixed‑price programs.

Risk assessment: Key tail risks include geopolitical de‑escalation, a U.S. budget reversal, export restrictions, or cost overruns that could swing margins — BA's total debt/capital ~118% creates acute financial vulnerability vs RTX ~37%. Immediate (days–weeks) sensitivity centers on contract announcements and guidance; short‑term (0–6 months) risks are quarterly results and FMS timing; long‑term (1–5 years) depends on program wins (F‑47, KC‑46) and sustained defense spend. Hidden dependencies: foreign military sales cadence, supplier single‑points‑of‑failure, and certification delays.

Trade implications: Tactical preference is long RTX and underweight/hedged exposure to BA. Implement a 2–4% long RTX equity position (target 12–24% 12‑month upside, stop‑loss 12%) and a smaller 1–2% BA hedge via 6–9 month put spread (defined risk) sized to cap drawdown. Consider a dollar‑neutral pair (long RTX / short BA) to capture relative backlog and balance‑sheet divergence; use options to express convexity — buy RTX 9–12 month call spreads if IV <40%, and buy BA 6–9 month 20% OTM put spreads to limit cost.

Contrarian angles: Consensus favors RTX but underestimates timing risk of international orders and munitions replenishment volatility — RTX up ~29% in 6 months may be partly priced for flawless execution. Conversely BA's commercial troubles may mean BDS upside is underpriced; a near‑term de‑risking of BA balance sheet (asset sales, debt paydown) would rapidly re‑rate shares. Historical precedent: defense spending cycles produce multi‑year rallies with mid‑cycle pullbacks; be prepared for 10–20% mean reversion if program or budget slippage occurs.

Key Decisions for Investors

• Establish a 3% long position in RTX (RTX) within 2–6 weeks, plan to hold 9–12 months, set an initial take‑profit at +20% and a hard stop at -12%; rationale: strong $103B backlog, lower leverage, durable bookings.
• Initiate a 1.5% hedged short exposure to BA via a 6–9 month 20% OTM put spread sized to offset 50% of the RTX position volatility; close if BA debt/capital falls below 80% or BA backlog growth >10% QoQ.
• Execute a dollar‑neutral pair trade (long RTX / short BA) equal‑weighted across positions, monitor monthly, and unwind after 12 months or if relative outperformance exceeds 25% (lock gains) or if RTX misses guidance.
• Use options tactically: buy RTX 9–12 month call spreads (target delta ~0.4–0.6) when IV30 <40% to limit premium; buy BA 6–9 month 20% OTM put spreads to cap downside risk if BA implied vol >35%.
• Overweight the aerospace & defense supplier subsector by +3–5% of portfolio weight (engines, sensors, munitions) and underweight commercial aerospace exposure by -3–5% given uneven recovery signals; rebalance on quarterly contract/margin updates.